These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30700848)

  • 21. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling.
    Li D; Ye C; Liu P; Sun T; Qin Y; Wan X
    Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2
    Meadows V; Kennedy L; Hargrove L; Demieville J; Meng F; Virani S; Reinhart E; Kyritsi K; Invernizzi P; Yang Z; Wu N; Liangpunsakul S; Alpini G; Francis H
    Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165557. PubMed ID: 31521820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
    Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
    Wu N; Meng F; Zhou T; Han Y; Kennedy L; Venter J; Francis H; DeMorrow S; Onori P; Invernizzi P; Bernuzzi F; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
    FASEB J; 2017 Oct; 31(10):4305-4324. PubMed ID: 28634212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2
    O'Brien A; Zhou T; White T; Medford A; Chen L; Kyritsi K; Wu N; Childs J; Stiles D; Ceci L; Chakraborty S; Ekser B; Baiocchi L; Carpino G; Gaudio E; Wu C; Kennedy L; Francis H; Alpini G; Glaser S
    Hepatol Commun; 2022 Jul; 6(7):1574-1588. PubMed ID: 35271760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.
    Kluwe J; Pradere JP; Gwak GY; Mencin A; De Minicis S; Osterreicher CH; Colmenero J; Bataller R; Schwabe RF
    Gastroenterology; 2010 Jan; 138(1):347-59. PubMed ID: 19782079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.
    Lei XF; Fu W; Kim-Kaneyama JR; Omoto T; Miyazaki T; Li B; Miyazaki A
    J Hepatol; 2016 Jan; 64(1):110-7. PubMed ID: 26334580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
    Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
    Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.
    Osawa Y; Hoshi M; Yasuda I; Saibara T; Moriwaki H; Kozawa O
    PLoS One; 2013; 8(6):e65251. PubMed ID: 23755201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation.
    Glaser S; Lam IP; Franchitto A; Gaudio E; Onori P; Chow BK; Wise C; Kopriva S; Venter J; White M; Ueno Y; Dostal D; Carpino G; Mancinelli R; Butler W; Chiasson V; DeMorrow S; Francis H; Alpini G
    Hepatology; 2010 Jul; 52(1):204-14. PubMed ID: 20578263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
    Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
    Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury.
    Villar-Lorenzo A; Rada P; Rey E; Marañón P; Arroba AI; Santamaría B; Sáiz J; Rupérez FJ; Barbas C; García-Monzón C; Valverde ÁM; González-Rodríguez Á
    Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31262748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
    Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis.
    Zhao G; Hatting M; Nevzorova YA; Peng J; Hu W; Boekschoten MV; Roskams T; Muller M; Gassler N; Liedtke C; Davis RJ; Cubero FJ; Trautwein C
    Gut; 2014 Jul; 63(7):1159-72. PubMed ID: 24037431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.
    Uchinami H; Seki E; Brenner DA; D'Armiento J
    Hepatology; 2006 Aug; 44(2):420-9. PubMed ID: 16871591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout Mice.
    Petrescu AD; Grant S; Williams E; Frampton G; Parks N; Blaney H; Davies M; John R; Reinhart EH; McMillin M; DeMorrow S
    Am J Pathol; 2020 Mar; 190(3):586-601. PubMed ID: 31953035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
    Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T
    Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions.
    Li X; Liu R; Wang Y; Zhu W; Zhao D; Wang X; Yang H; Gurley EC; Chen W; Hylemon PB; Zhou H
    Cells; 2020 Jan; 9(1):. PubMed ID: 31940841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α7-nAChR Knockout Mice Decreases Biliary Hyperplasia and Liver Fibrosis in Cholestatic Bile Duct-Ligated Mice.
    Ehrlich L; O'Brien A; Hall C; White T; Chen L; Wu N; Venter J; Scrushy M; Mubarak M; Meng F; Dostal D; Wu C; Lairmore TC; Alpini G; Glaser S
    Gene Expr; 2018 Aug; 18(3):197-207. PubMed ID: 29580318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling.
    Meadows V; Kennedy L; Ekser B; Kyritsi K; Kundu D; Zhou T; Chen L; Pham L; Wu N; Demieville J; Hargrove L; Glaser S; Alpini G; Francis H
    Hepatology; 2021 Nov; 74(5):2684-2698. PubMed ID: 34164827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.